|
Video: What is a Stock Split?
|
|
180 Life Sciences is a biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing research, and, where appropriate, combination therapy. Co.'s product development platforms that are focused on different diseases or medical conditions, and that target different factors, molecules or proteins, include: anti-tumor necrosis factor (TNF) platform, which is focusing on fibrosis and anti-TNF; synthetic cannabidiol analogs platform, which is focusing on drugs which are synthetic cannabidiol or cannabigerol analogues; and alpha 7 nicotinic acetylcholine receptor (a7nAChR) platform, which is focusing on a7nAChR. According to our ATNF split history records, 180 Life Sciences has had 2 splits. | |
|
180 Life Sciences (ATNF) has 2 splits in our ATNF split history database. The first split for ATNF took place on December 19, 2022. This was a 1 for 20 reverse split, meaning for each 20 shares of ATNF owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split. ATNF's second split took place on February 28, 2024. This was a 1 for 19 reverse split, meaning for each 19 shares of ATNF owned pre-split, the shareholder now owned 1 share. For example, a 50 share position pre-split, became a 2.63157894736842 share position following the split.
When a company such as 180 Life Sciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ATNF split history from start to finish, an original position size of 1000 shares would have turned into 2.63157894736842 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into 180 Life Sciences shares, starting with a $10,000 purchase of ATNF, presented on a split-history-adjusted basis factoring in the complete ATNF split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/28/2017 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$3,686.00 |
|
End price/share: |
$1.80 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.95% |
|
Average Annual Total Return: |
-67.24% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4.88 |
|
Years: |
6.83 |
|
|
|
Date |
Ratio |
12/19/2022 | 1 for 20 | 02/28/2024 | 1 for 19 |
|
|